Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Cambrex Will Make Drug Polymer For Dow

by Ann M. Thayer
February 18, 2013 | A version of this story appeared in Volume 91, Issue 7

Cambrex will manufacture Dow Chemical’s hydroxypropyl methylcellulose acetate succinate, a polymer used in making solid dispersions of active pharmaceutical ingredients. Cambrex is building a plant to produce the polymer at its Karlskoga, Sweden, site and expects to have it operating by the end of 2013. Full-scale production will allow Dow to commercialize the drug-solubility enhancer. Since late 2012, Dow has worked with Oregon-based Bend Research on combining its polymeric materials with Bend’s formulation technologies to overcome problems with poorly soluble oral drugs.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.